期刊文献+

高效液相色谱法测定中国健康志愿者血清中坎地沙坦及坎地沙坦西酯片的人体药动学 被引量:3

Determination of candesartan in human serum using high performance liquid chromatography and pharmacokinetics of candesartan cilexetil tablets in Chinese healthy volunteers
下载PDF
导出
摘要 目的建立高效液相色谱-荧光检测法测定人血清中坎地沙坦的方法,考察坎地沙坦西酯片在中国健康志愿者体内的药动学参数。方法以萘普生为内标,按内标法定量。血清样品经盐酸酸化后,加入甲基叔丁基醚萃取,离心分离,取上清液置于已加入1,3-丙二醇的离心管,吹干后用流动相溶解进样。色谱柱:YMC ODS柱(250mm×4.6mm,5μm),柱温:30℃;流动相:10mmol/L磷酸二氢钾溶液(磷酸调pH到3.0)∶乙腈=60∶40,流速:1.0mL/min。荧光检测波长:λex270nm,λem390nm。用该方法测定20名健康志愿者口服坎地沙坦西酯片8mg后血清中的药物浓度,进行药动学分析。结果坎地沙坦和萘普生的保留时间分别为10.4min和16.5min;坎地沙坦的线性范围是1.01~202μg/L;日内、日间RSD小于10.39%;方法回收率在94.05%~112.80%范围内。结论此方法适合人体药动学的血样分析,结果准确可靠。 Objective To develop a sensitive and specific method for the determination of candesartan in human serum and to study the pharmacokinetics characteristics of candesartan cilexetil tablets in Chinese healthy volunteers using this method. Methods The samples were extracted from serum with diethyl ether. Chromatography was performed on an YMC ODS column (250 mm × 4.6 mm i. d. , 5 μm) with a mobile phase consisting of 10 mmol/L potassium dihydrogen phosphate (adjusted to pH 3. 0 with phosphoric acid) and acetonitrile (60 : 40, V/V) at a flow rate of 1. 0 mL/min. Quantification was performed by fluorescence detection at an excitation wavelength of 270 nm and an emission wavelength of 390 nm. A single oral dose of 8mg candesartan cilexetil tablet was given to 20 healthy volunteers. The candesartan concentrations in serum were determined by the above-mentioned method. The main pharmacokinetic parameters were detected and calculated. Results The linear range of candesartan concentration was 1.01 to 202 μg/L in serum with a correlation coefficient (r) of 0. 999 7. The relative standard deviations (RSDs) of intra-day and inter-day assays were 5.22% -9. 14% and 3.58% - 10. 39%, respectively. Conclusions This method proved to be sensitive and reproducible for pharmacokinetic studies of candesartan cilexetil in healthy volunteers after a single oral administration (8 mg).
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2008年第4期552-555,共4页 Fudan University Journal of Medical Sciences
关键词 坎地沙坦 坎地沙坦西酯 高效液相色谱 血药浓度 药动学 candesartan candesartan cilexetil high performance liquid chromatography human ,serum pharmacokinetics
  • 相关文献

参考文献8

  • 1Stoukides CA,McVoy HJ, Kaul AF. Candesartan cilexetil: an angiotensin Ⅱ receptor blocker[J].Ann Pharmacother.1999, 33(12):1 287- 1 298.
  • 2Gleiter CH. Morike KE. Clinical pharmacokinetics of candesartan[J].Clin Pharmacokinet .2002,41 ( 1 ):7 - 17.
  • 3Huhner R, Hogemann AM, Sunzel M, et al. Pharmacokinetics of candesartan after single and repeated doses of candesartan cilexetil in young and elderly healthy volunteers[J]. J Hum Hypertens. 1997, 11(Suppl 2) :S19 - 25.
  • 4Lee JW, Naidong W. Johnson T. et al. Development and validation of column-switching high-performance liquid chromatographic methods for the determination of a potent AII receptor antagonist. TCV-116, and its metaholites in human serum and urine[J]. J Chromatogr B Biomed Appl, 1995 (670):287- 291.
  • 5Helene Stenhoff, Per-Olof Lagerstrom. Cathrine Andersen. Determination of candesartan cilexetil, eandesartan and a metabolite in human plasma and urine by liquid chromatography and fluorometric detection[J].J Chromatogr B.1999(731):411-417.
  • 6Gonzalez L. Lopez JA, Alonso RM, et al. Fast screening method for the determination of angiotensin Ⅱ receptor antagonists in human plasma by high-performance liquid chromatography with fluorometric detection[J]. J Chromatogr A ,20(12(949) :49 - 60.
  • 7Jing Nie, Min Zhang, Yi Fan, et al. Biocompatible in tube solidphase microextraction coupled to HPLC for the determination of angiotensin Ⅱ receptor antagonists in human plasma and urine[J]. J Chromatogr B, 2005 (828) : 62 - 69.
  • 8袁京群,李士敏,王华,俞佳,景文涛.反相高效液相色谱荧光检测法测定人血浆中坎地沙坦浓度[J].药物分析杂志,2006,26(6):761-763. 被引量:1

二级参考文献4

  • 1Miyabayashi T, Okuda T, Motohashi M, et al. Quantitation of a new potent angiotensin Ⅱ receptor antagonist, TCV - 116, and its metabolites in human serum and urine. J Chromatogr B Biomed Appl, 1996,677 : 123
  • 2Lee JW,Naidong W,Johnson T,et al. Development and validation of column- switching high -performance liquid chromatographic methods for the determination of a potent AⅡ receptor antagonist, TCV -116, and its metabolites in human serum and urine. J Chromatogr B Biomed Appl , 1995,670:287
  • 3Stenhoff Helene, Lagerstrom Per - Olof, Andersen Cathrine. Determination of candesartan cilexetil, candesartan and a metabolite in human plasma and urine by liquid chromatography and fluorometric detection. J Chromatogr Biomed Sci Appl , 1999,731:411
  • 4唐显军.坎地沙坦——血管紧张素受体拮抗剂的研究进展[J].心血管病学进展,2004,25(3):172-175. 被引量:33

同被引文献21

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部